Shirt a Phobia

Sample Page

Not to be confused with Propisergide.

Proterguride (INNTooltip International Nonproprietary Name; developmental code names VUFB-13416, ZK-39437), also known as 6-propylterguride or 6-propyl-9,10-dihydrolisuride, is a dopamine agonist of the ergoline family described as a prolactin inhibitor and antiparkinsonian agent which was never marketed.[1][2][3][4][5] It is closely structurally related to certain other ergolines like terguride and lisuride.[1][4] Besides dopamine receptors, the drug also interacts with serotonin, adrenergic, and histamine receptors.[5] Proterguride was first described in the literature by at least 1981.[1]

See also

References

  1. ^ a b c Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. ISBN 978-1-4757-2085-3. Retrieved 30 June 2025.
  2. ^ Milne G (8 May 2018). Drugs: Synonyms and Properties. Routledge. ISBN 978-1-351-78990-5. Retrieved 30 June 2025.
  3. ^ Negwer M (2001). Organic-chemical Drugs and Their Synonyms: An International Survey. Wiley-VCH. ISBN 978-3-527-30247-5. Retrieved 30 June 2025.
  4. ^ a b Ita K (June 2017). “Recent trends in the transdermal delivery of therapeutic agents used for the management of neurodegenerative diseases”. Journal of Drug Targeting. 25 (5): 406–419. doi:10.1080/1061186X.2016.1245310. PMID 27701893. Proterguride (N6-propylterguride or N6-propyldihydrolisuride) is an ergoline derivative with potent dopaminergic activity [124, 125]. It has been reported that strong dopaminergic activity can be achieved at plasma concentrations below 50 pg/mL [125]. Physiologic dopamine receptor stimulation in the human striatum can be simulated by continuous administration of proterguride (PT) [125].
  5. ^ a b Schurad B, Horowski R, Jähnichen S, Görnemann T, Tack J, Pertz HH (April 2006). “Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson’s disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors”. Life Sciences. 78 (20): 2358–2364. doi:10.1016/j.lfs.2005.09.046. PMID 16310806.